Enlivex Therapeutics Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$1.16

+0.00 (+0.00%)

As of Feb 8, 2:00 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +3,068.1% upside

Low Target $26.33

Average Target $36.75

High Target $40.94

Current Price $1.16

Current
$1.16

Target
$36.75

$26.33 $36.75 avg $40.94

Scenario Analysis

Bear Case

$26.33

2,169.8%

Low target

Base Case

$36.75

+3,068.1%

Avg target

Bull Case

$40.94

+3,429.3%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$32.43

-96.4% from high

52-Week Low

$19.15

+-93.9% from low

Target vs 52W High

$36.75

+13.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%